Spero Therapeutics
At Spero Therapeutics, it is our hope to advance novel treatments for rare diseases and MDR bacterial infections. Since our inception in
- November 8, 2024
global, IT, Learn, QSOL Clients, targets
- October 25, 2024
Today, I shared my annual letter to shareholders, and I invite you to read it. I’ve been reflecting on how we stay relevant and continue reinventing ourselves in this age of AI. This includes our deep commitment to security, quality, and AI innovation – for our customers and the world.
The post Today, I shared my annual letter to shareholders, and I invite you to read it. I’ve been reflecting
- February 26, 2024
We’re announcing a multi-year partnership with Mistral AI, as we build on our commitment to offer customers the best choice of open and foundation models on Azure.
The post We’re announcing a multi-year partnership with Mistral AI, as we build on our commitment to offer customers the